Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
130,702,820
-
Total 13F shares
-
21,711,137
-
Share change
-
-2,133,252
-
Total reported value
-
$112,682,000
-
Put/Call ratio
-
469%
-
Price per share
-
$5.19
-
Number of holders
-
59
-
Value change
-
-$9,997,030
-
Number of buys
-
25
-
Number of sells
-
27
Institutional Holders of Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH) as of Q1 2018
As of 31 Mar 2018,
Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH) was held by
59 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
21,711,137 shares.
The largest 10 holders included
NEA Management Company, LLC, FMR LLC, Polar Capital LLP, FRANKLIN RESOURCES INC, GOLDMAN SACHS GROUP INC, Vivo Capital, LLC, BlackRock Inc., ORBIMED ADVISORS LLC, MORGAN STANLEY, and Alyeska Investment Group, L.P..
This page lists
60
institutional shareholders reporting positions in this security
for the Q1 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.